Skip to main content
logo
UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
306.00
-4.61 (-1.48%)
At close: Feb 26, 2026

UCB SA Revenue

In the year 2025, UCB SA had annual revenue of 7.74B EUR with 25.83% growth. UCB SA had revenue of 3.49B in the half year ending June 30, 2025, with 38.43% growth.

Revenue
7.74B EUR
Revenue Growth
+25.83%
P/S Ratio
6.24
Revenue / Employee
900.12K EUR
Employees
8,600
Market Cap
56.75B USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.74B1.59B25.83%
Dec 31, 20246.15B970.00M18.72%
Dec 31, 20235.18B-265.00M-4.87%
Dec 31, 20225.45B-330.00M-5.71%
Dec 31, 20215.78B430.00M8.04%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
BioStem Technologies292.21M
Vaxart148.20M
Silence Therapeutics25.83M
Nuo Therapeutics2.61M
Northwest Biotherapeutics937.00K
ZIVO Bioscience209.03K
Arch Biopartners198.11K
Revenue Rankings

UCB SA News

More News